Cervical Artery Dissection in Stroke Study (CADISS)

NCT00238667 Phase 3 COMPLETED

This is a feasibility study to determine if a sufficient number of patients can be recruited throughout the United Kingdom and whether sufficient endpoints can be generated for a full scale therapeutic trial of anticoagulants versus antiplatelets in acute cervical artery dissection treatment.

Details

Lead sponsor	St George's, University of London
Phase	Phase 3
Status	COMPLETED
Enrolment	250
Start date	2005-11
Completion	2014-05

Conditions

• Cervical Artery Dissection
• Carotid Artery Dissection
• Vertebral Artery Dissection
• Stroke

Interventions

• Antiplatelet (Aspirin, Dipyridamole, clopidogrel)
• Anticoagulant (Unfractionated Heparin, LMW Heparin, Warfarin)

Countries

United Kingdom